Wen Jiang

发表

The first potent and selective non-imidazole human histamine H4 receptor antagonists.

J. A. Jablonowski, Cheryl A. Grice, W. Chai, 2003, Journal of medicinal chemistry.

The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors.

Cheryl A. Grice, Jianmei Wei, Wen Jiang, 2006, Bioorganic & medicinal chemistry letters.

Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors.

Wen Jiang, R. Knabb, A. Rendina, 2013, Bioorganic & medicinal chemistry letters.

Design, synthesis, and antiviral properties of 4'-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479.

Wen Jiang, R. Devos, J. Symons, 2007, Bioorganic & medicinal chemistry letters.

Neutral macrocyclic factor VIIa inhibitors.

Brandon L. Parkhurst, Wen Jiang, D. Cheney, 2017, Bioorganic & medicinal chemistry letters.

Discovery of Phenylglycine Lactams as Potent Neutral Factor VIIa Inhibitors.

Brandon L. Parkhurst, Wen Jiang, D. Cheney, 2016, ACS medicinal chemistry letters.

Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors.

Wen Jiang, D. Cheney, Yan Zou, 2016, Bioorganic & medicinal chemistry letters.

Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex.

Brandon L. Parkhurst, Wen Jiang, D. Cheney, 2016, Journal of medicinal chemistry.

Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors.

Wen Jiang, D. Cheney, Yan Zou, 2014, ACS medicinal chemistry letters.

Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes.

Wen Jiang, Jian Yin, Jing Han, 2020, Journal of medicinal chemistry.

Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists.

J. A. Jablonowski, Cheryl A. Grice, W. Chai, 2005, Journal of medicinal chemistry.

Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors.

Jianmei Wei, Wen Jiang, R. Thurmond, 2005, Bioorganic & medicinal chemistry letters.

N-(3,5-Dichloro-4-(2,4,6-trichlorophenoxy)phenyl)benzenesulfonamide: A new dual-target inhibitor of mitochondrial complex II and complex III via structural simplification.

Wen Jiang, Cheng Chen, Hua Cheng, 2019, Bioorganic & medicinal chemistry.

Self-assembled nano-micelles of lactoferrin peptides: Structure, physicochemical properties, and application for encapsulating and delivering curcumin.

Wen Jiang, D. Julian Mcclements, Fuguo Liu, 2022, Food chemistry.

Pea protein isolate-inulin conjugates prepared by pH-shift treatment and ultrasonic-enhanced glycosylation: Structural and functional properties.

Wen Jiang, Xuebo Liu, D. Julian Mcclements, 2022, Food chemistry.

Peptide-based long-acting co-agonists of GLP-1 and cholecystokinin 1 receptors as novel anti-diabesity agents.

Wen Jiang, Jing Han, Yongliang Yuan, 2022, European journal of medicinal chemistry.

Discovery of Novel Small-Molecule Antiangiogenesis Agents to Treat Diabetic Retinopathy.

Wen Jiang, Donghwa Kim, Sanghee Kim, 2021, Journal of medicinal chemistry.

Pyrazole-based cathepsin S inhibitors with improved cellular potency.

Wen Jiang, James P Edwards, Lars Karlsson, 2007, Bioorganic & medicinal chemistry letters.

N-(4-(2-chloro-4-(trifluoromethyl)phenoxy)phenyl)picolinamide as a new inhibitor of mitochondrial complex III: Synthesis, biological evaluation and computational simulations.

Wen Jiang, Cheng Chen, Hua Cheng, 2020, Bioorganic & medicinal chemistry letters.

Molecular Determinants of Ligand Binding to H4R Species Variants

Wen Jiang, Chris de Graaf, Rob Leurs, 2010, Molecular Pharmacology.